1.
Jauch EC,
Saver JL,
Adams HP Jr,
Bruno A,
Connors JJB,
Demaerschalk BM,
et al.
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke J Cereb Circ.
marzo de 2013;44(3):870-947.
2.
Tissue plasminogen activator for acute ischemic stroke.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
N Engl J Med.
14 de diciembre de 1995;333(24):1581-7.
3.
Lees KR,
Bluhmki E,
von Kummer R,
Brott TG,
Toni D,
Grotta JC,
et al.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS,
ATLANTIS,
NINDS,
and EPITHET trials.
Lancet.
15 de mayo de 2010;375(9727):1695-703.
4.
Wardlaw JM,
Muir KW,
Macleod M-J,
Weir C,
McVerry F,
Carpenter T,
et al.
Clinical relevance and practical implications of trials of perfusion and angiographic imaging in patients with acute ischaemic stroke: a multicentre cohort imaging study.
J Neurol Neurosurg Psychiatry.
septiembre de 2013;84(9):1001-7.
5.
Grotta J.
Timing of thrombolysis for acute ischemic stroke: «timing is everything» or «everyone is different».
Ann N Y Acad Sci.
septiembre de 2012;1268:141-4.
6.
Konstas AA,
Goldmakher GV,
Lee T-Y,
Lev MH.
Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke,
part 1: Theoretic basis.
AJNR Am J Neuroradiol.
abril de 2009;30(4):662-8.
7.
Konstas AA,
Goldmakher GV,
Lee T-Y,
Lev MH.
Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke,
part 2: technical implementations.
AJNR Am J Neuroradiol.
mayo de 2009;30(5):885-92.
8.
Schaefer PW,
Roccatagliata L,
Ledezma C,
Hoh B,
Schwamm LH,
Koroshetz W,
et al.
First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy.
AJNR Am J Neuroradiol.
enero de 2006;27(1):20-5.
9.
Wintermark M,
Flanders AE,
Velthuis B,
Meuli R,
van Leeuwen M,
Goldsher D,
et al.
Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke.
Stroke J Cereb Circ.
abril de 2006;37(4):979-85.
10.
Wintermark M,
Albers GW,
Alexandrov AV,
Alger JR,
Bammer R,
Baron J-C,
et al.
Acute stroke imaging research roadmap.
Stroke J Cereb Circ.
mayo de 2008;39(5):1621-8.
11.
Dani KA,
Thomas RGR,
Chappell FM,
Shuler K,
MacLeod MJ,
Muir KW,
et al.
Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds.
Ann Neurol.
septiembre de 2011;70(3):384-401.
12.
Dani KA,
Thomas RGR,
Chappell FM,
Shuler K,
Muir KW,
Wardlaw JM.
Systematic review of perfusion imaging with computed tomography and magnetic resonance in acute ischemic stroke: heterogeneity of acquisition and postprocessing parameters: a translational medicine research collaboration multicentre acute stroke imaging study.
Stroke J Cereb Circ.
febrero de 2012;43(2):563-6.
13.
Wintermark M,
Albers GW,
Broderick JP,
Demchuk AM,
Fiebach JB,
Fiehler J,
et al.
Acute Stroke Imaging Research Roadmap II.
Stroke J Cereb Circ.
septiembre de 2013;44(9):2628-39.
14.
Davis SM,
Donnan GA,
Parsons MW,
Levi C,
Butcher KS,
Peeters A,
et al.
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
Lancet Neurol.
abril de 2008;7(4):299-309.
15.
Hacke W,
Albers G,
Al-Rawi Y,
Bogousslavsky J,
Davalos A,
Eliasziw M,
et al.
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
Stroke J Cereb Circ.
enero de 2005;36(1):66-73.
16.
Hacke W,
Furlan AJ,
Al-Rawi Y,
Davalos A,
Fiebach JB,
Gruber F,
et al.
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective,
randomised,
double-blind,
placebo-controlled study.
Lancet Neurol.
febrero de 2009;8(2):141-50.
17.
Furlan AJ,
Eyding D,
Albers GW,
Al-Rawi Y,
Lees KR,
Rowley HA,
et al.
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.
Stroke J Cereb Circ.
mayo de 2006;37(5):1227-31.
18.
Kidwell CS,
Jahan R,
Gornbein J,
Alger JR,
Nenov V,
Ajani Z,
et al.
A trial of imaging selection and endovascular treatment for ischemic stroke.
N Engl J Med.
7 de marzo de 2013;368(10):914-23.
19.
Smith WS,
Sung G,
Saver J,
Budzik R,
Duckwiler G,
Liebeskind DS,
et al.
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial.
Stroke J Cereb Circ.
abril de 2008;39(4):1205-12.
20.
Molina CA,
Alexandrov AV,
Demchuk AM,
Saqqur M,
Uchino K,
Alvarez-Sabín J.
Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen Activator.
Stroke.
1 de enero de 2004;35(1):151-6.
21.
Saqqur M,
Uchino K,
Demchuk AM,
Molina CA,
Garami Z,
Calleja S,
et al.
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.
Stroke J Cereb Circ.
marzo de 2007;38(3):948-54.
22.
Dubey P,
Pandey S,
Moonis G.
Acute stroke imaging: recent updates.
Stroke Res Treat.
2013;2013:767212.
23.
Maija R,
Gaida K,
Karlis K,
Evija M.
Perfusion computed tomography relative threshold values in definition of acute stroke lesions.
Acta Radiol Short Reports.
2013;2(3):2047981613486099.
24.
Collins P,
Dani K,
Moreton F,
McVerry F,
Macdougall N,
Macleod MJ,
et al.
CT Perfusion in acute ischaemic STROKE: do we cover the lesion and what does it mean?.
J Neurol Neurosurg Psychiatry.
noviembre de 2013;84(11):e2.
25.
Collins PD,
Dani KA,
Moreton F,
Huang X,
Macdougall NJ,
McVerry F,
et al.
Large CT PERFUSION-Defined MISMATCH predicts early improvement after IV Thrombolysis in acute ischaemic Stroke.
J Neurol Neurosurg Psychiatry.
noviembre de 2013;84(11):e2.